Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapy of recalcitrant macular edema with long-term intravitreal steroid implants in aphakic or iris-lens diaphragm–disrupted eyes
DRKS00020282Phase 4Recruiting
- Sponsor
- LMU Eye Clinic
- Start
- Dec 2019
- Modality
- Small Molecules, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fluocinolone and ozurdex in macular edema, sponsored by LMU Eye Clinic. Started Dec 2019; status: recruiting.
02
Drugs
fluocinoloneozurdex
03
Conditions
macular edema
Beyond the preview
Go deeper on DRKS00020282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00020282.